Individual Tumor Profiling
Has Tumor Molecular Profiling Enabled More Effective and Less Toxic Cancer Treatment?
Top 10 Under 40
Up-and-Coming Stars Shine in Biopharma Research and Business
Podcast: FDA’s New Commissioner Hits the Ground Running
Scott Gottlieb, M.D., Commits to Speeding Up Drug Reviews, and Maintaining Safety and Efficacy
Liquid Biopsies Remain Wait and See for Some Clinicians
Circulating Biomarker Assays Promise to Refresh Cancer Profiling and Monitoring Practices
The Fate of Terminally Ill Patients
The Death with Dignity Act, which was approved in November in Washington state, took effect on March 5. Physicians at participating hospitals are now allowed to prescribe lethal doses of medication to terminally ill patients who have less than seven months to live under very strict guidelines. Healthcare facilities as well as health providers are divided on this subject, so we'd like to know how you feel.